Bionik Laboratories Corp.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Bionik Laboratories Corp.
The SEEK spin-out ConserV Bioscience is developing a broad-spectrum coronavirus vaccine, aiming to get ahead of the arrival of new strains of the virus.
Presenting Phase IIb data on FLU-v, specialized CRO hVIVO now hopes to secure a big pharma partner for Phase III studies and commercialization of the universal flu vaccine candidate. The product has been developed in a joint venture with SEEK.
Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bi-monthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in March and April 2017.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
- Medical Devices
- Hospitals, Nursing Homes, Institutions
- Managed Care, Insurance, Integrated Systems
- Radiofrequency Devices
- Rehabilitation Equipment and Devices
- Other Names / Subsidiaries
- Interactive Motion Technologies
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.